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Materials and Methods  
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage 
through an activated alumina column under argon.1 Reaction progress was monitored by thin-
layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck 
silica gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence 
quenching or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel (particle size 40–
63 nm) was used for flash chromatography.  1H NMR spectra were recorded on Varian Inova 
500 MHz, Varian 400 MHz, and Bruker 400 MHz spectrometers and are reported relative to 
residual CHCl3 (δ 7.26 ppm).  13C NMR spectra were recorded on a Varian Inova 500 MHz 
spectrometer (125 MHz), a Varian 400 MHz spectrometer (100 MHz), and Bruker 400 MHz 
spectrometers (100 MHz) and are reported relative to CHCl3 (δ 77.16 ppm). Data for 1H NMR 
are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br d = broad doublet.  
Data for 13C NMR are reported in terms of chemical shifts (δ ppm) Some reported spectra 
include minor solvent impurities of water (δ 1.56ppm), ethyl acetate (δ 4.12, 2.05, 1.26 ppm), 
methylene chloride (δ 5.30 ppm), acetone (δ 2.17 ppm), grease (δ 1.26, 0.86 ppm), and/or silicon 
grease (δ 0.07 ppm), which do not impact product assignments. Most NMR spectra are 
complicated by rotational isomerism about amide bonds. This behavior is illustrated by variable-
temperature NMR spectra of compound 4e in DMSO (p. S102). IR spectra were obtained by use 
of a Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin 
films deposited on NaCl plates and reported in frequency of absorption (cm–1).  Optical rotations 
were measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 nm), using 
a 100 mm path-length cell.  Analytical SFC was performed with a Mettler SFC supercritical CO2 
analytical chromatography system utilizing Chiralpak (AD-H, AS-H or IC) or Chiralcel (OD-H, 
OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. 
High resolution mass spectra (HRMS) were obtained from Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric pressure 
chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+).  Absolute 
stereochemistry is assigned by analogy to previous results by our group.2 
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Reagents were purchased from commercial sources and used as received unless otherwise 
stated.  Ligands (S)-(CF3)3-t-BuPHOX and (S)-Ty-PHOX were prepared according to literature 
procedures.3,4 
List of Abbreviations: 
ee – enantiomeric excess, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, IPA – isopropanol, An = 4-anisoyl, MeCy = methylcyclohexane 
 
General Procedure for Pd-Catalyzed Allylic Alkylation Reactions 
 
In a N2 filled glovebox, Pd2(dba)3 (4 mol %) or Pd2(pmdba)3 (4 mol %) and (S)-(CF3)3-t-
BuPHOX (10 mol %) were suspended in methylcyclohexane (2 mL) in a 20 mL glass vial. After 
stirring for 20 minutes at 25 °C, the appropriate diazepanone (1.0 equiv) and methylcyclohexane 
(5.2 mL, total substrate concentration 0.014 M) were added to the pre-stirred catalyst solution. 
The vial was then sealed and heated to 40 °C. After full consumption of starting material, as 
monitored by TLC, the reaction mixture was exposed to air. The crude reaction mixture was 
loaded directly onto a flash column and the product was isolated by silica gel flash 
chromatography. 
 
tert-butyl (S)-6-allyl-4-benzoyl-6-benzyl-5-oxo-1,4-diazepane-1-carboxylate (4a) 
Prepared according to the general procedure with allyl ester 3a (51.2 mg, 0.104 mmol, 1.0 
RN
NBoc
O R1
O
O
Pd2(dba)3 or Pd2(pmdba)3 (4 mol %)
(S)-(CF3)3-t-BuPHOX (10 mol %)
methylcyclohexane, 40 °C RN
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O R1
P N
O
t-Bu
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(S)-(CF3)3-t-BuPHOX
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equiv), Pd2(pmdba)3 (4.4 mg, 0.004 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (5.9 mg, 0.01 
mmol, 10 mol %). Purified by silica gel flash chromatography (15% EtOAc/hexanes) to provide 
benzyl diazepanone 4a as a colorless oil (43.4 mg, 0.0967 mmol, 93% yield, 90% ee); 1H NMR 
(400 MHz, CDCl3) δ 7.56 – 7.40 (m, 3H), 7.40 – 7.32 (m, 2H), 7.32 – 7.19 (m, 3H), 7.19 – 7.00 
(m, 2H), 5.88 (br s, 1H), 5.26 – 5.07 (m, 2H), 4.26 – 4.03 (m, 1H), 3.94 (d, J = 15.4 Hz, 1H), 
3.73 (d, J = 42.2 Hz, 1H), 3.54 (d, J = 15.3 Hz, 1H), 3.40 (s, 2H), 3.09 (dd, J = 61.0, 13.7 Hz, 
1H), 2.94 – 2.34 (m, 3H), 1.48 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 179.2, 174.8, 156.0, 
155.4, 136.6, 136.4, 133.0, 131.5, 130.8, 128.6, 128.4, 127.8, 127.1, 120.0, 119.7, 80.8, 54.3, 
53.9, 49.1, 47.4, 46.9, 42.5, 42.0, 41.5, 40.3, 28.5; IR (Neat Film, NaCl) 3062, 2975, 2928, 1693, 
1682, 1601, 1452, 1415, 1392, 1365, 1322, 1283, 1246, 1156, 1044, 978, 917, 865, 728, 697 cm–
1; HRMS (MM: ESI-APCI): m/z calc’d for C27H33N2O4 [M+H]
+: 449.2435, found 449.2429; 
[α]D22.4 +14.19 (c 0.66, CHCl3); SFC conditions: 20% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): major = 3.51, minor = 2.71. 
 
 
BzN
NBoc
OMe
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tert-butyl (R)-6-allyl-4-benzoyl-6-methyl-5-oxo-1,4-diazepane-1-carboxylate (4b) 
Prepared according to the general procedure with allyl ester 3b (39.0 mg, 0.0937 mmol, 1.0 
equiv), Pd2(pmdba)3 (4.4 mg, 0.004 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (5.9 mg, 0.01 
mmol, 10 mol %). Purified by silica gel flash chromatography (20% EtOAc/hexanes) to provide 
methyl diazepanone 4b as a colorless, waxy solid (32.3 mg, 0.868 mmol, 93% yield, 90% ee); 1H 
NMR (400 MHz, CDCl3) δ 7.54 – 7.43 (m, 3H), 7.43 – 7.32 (m, 2H), 5.74 (ddt, J = 17.1, 9.9, 7.4 
Hz, 1H), 5.19 – 5.06 (m, 2H), 4.30 – 3.89 (m, 3H), 3.85 – 3.69 (m, 1H), 3.66 – 3.34 (m, 2H), 
2.63 – 2.20 (m, 2H), 1.50 (s, 9H), 1.30 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 180.8, 174.5, 
155.4, 155.0, 136.3, 132.9, 131.4, 128.3, 127.5, 119.5, 80.7, 50.9, 49.9, 47.2, 46.5, 42.5, 42.1, 
41.8, 28.4, 23.5, 23.1; IR (Neat Film, NaCl) 2976, 2933, 1694, 1450, 1418, 1392, 1366, 1323, 
1284, 1246, 1146, 1057, 983, 917, 868, 768, 729, 696 cm–1; HRMS (MM: ESI-APCI): m/z calc’d 
for C21H29N2O4 [M+H]+: 373.2122, found 373.2117; [α]D22.31 –12.69 (c 1.0, CHCl3); SFC 
Conditions: 20% IPA, 2.5 mL/min, Chiralpak IC column, λ = 210 nm, tR (min): minor = 4.31, 
major = 5.68. 
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tert-butyl (R)-6-allyl-6-methyl-5-oxo-4-(4-(trifluoromethyl)benzoyl)-1,4-diazepane-1-
carboxylate (4c) 
Prepared according to the general procedure with allyl ester 3c (55.3 mg, 0.114 mmol, 1.0 
equiv), Pd2(dba)3 (4.2 mg, 4.57 µmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (6.7 mg, 0.011 
mmol, 10 mol %). Purified by silica gel flash chromatography (20% EtOAc/hexanes) to provide 
methyl diazepanone 4c as a colorless oil (45.1 mg, 0.102 mmol, 90% yield, 92% ee); 1H NMR 
(400 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2H), 7.55 (d, J = 8.2 Hz, 2H), 5.71 (ddt, J = 17.2, 10.1, 
7.4 Hz, 1H), 5.23 – 5.07 (m, 2H), 4.21 – 4.03 (m, 2H), 4.02 – 3.64 (m, 2H), 3.58 – 3.38 (m, 2H), 
2.59 – 2.21 (m, 2H), 1.49 (s, 9H), 1.29 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 181.0, 180.8, 
173.1, 155.4, 155.1 140.0, 132.8 (q, JC-F = 32.9 Hz), 132.7, 127.6, 125.5 (q, JC-F = 3.7 Hz), 123.7 
(q, JC-F = 272.5 Hz), 119.9, 81.0, 50.9, 50.0, 47.2, 46.4, 42.4, 42.0, 41.8, 28.5, 23.6, 23.3; IR 
(Neat Film, NaCl) 3366, 3077, 2978, 2934, 1694, 1452, 1410, 1394, 1367, 1326, 1248, 1167, 
1147, 1066, 1014, 984, 925, 852, 764 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for 
C22H31F3N3O4 [M+NH4]+: 458.2261, found 458.2250; [α]D22.6 –12.32 (c 1.0, CHCl3); SFC 
Conditions: 5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.49, 
major = 5.86. 
 
(p-F3C-Bz)N
NBoc
OMe
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 	
 
S7 
 
 
tert-butyl (R)-6-allyl-4-(4-methoxybenzoyl)-6-methyl-5-oxo-1,4-diazepane-1-carboxylate 
(4d) 
Prepared according to the general procedure with allyl ester 3d (45.8 mg, 0.103 mmol, 1.0 
equiv), Pd2(dba)3 (3.7 mg, 0.004 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (5.9 mg, 0.01 
mmol, 10 mol %). Purified by silica gel flash chromatography (20% EtOAc/hexanes) to provide 
methyl diazepanone 4d as a colorless oil (38.9 mg, 0.0966 mmol, 94% yield, 94% ee); 1H NMR 
(400 MHz, CDCl3) δ 7.62 – 7.44 (m, 2H), 6.95 – 6.75 (m, 2H), 5.76 (m, 1H), 5.26 – 4.99 (m, 
2H), 4.24 – 3.87 (m, 3H), 3.83 (s, 3H), 3.75 (m, 1H), 3.59 – 3.37 (m, 2H), 2.60 – 2.25 (m, 2H), 
1.49 (s, 9H), 1.31 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 180.7, 180.6, 174.3, 162.5, 155.4, 
155.0, 133.0, 130.1, 128.1, 119.4, 113.6, 80.7, 55.4, 50.8, 49.8, 47.4, 46.6, 42.7, 42.4, 28.4, 23.5, 
23.1; IR (Neat Film, NaCl) 3352, 3076, 2975, 2932, 2841, 2568, 1690, 1605, 1579, 1542, 1511, 
1458, 1420, 1392, 1366, 1322, 1284, 1256, 1214, 1168, 1146, 1056, 1032, 984, 924, 868, 842, 
807, 762, 743, 736, 650, 633, 621, 608 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for 
C22H31N2O5 [M+H]+: 403.2227, found 403.2225; [α]D22.45 –40.51 (c 1.0, CHCl3); SFC 
Conditions: 20% MeOH, 2.5 mL/min, Chiralpak IC column, λ = 210 nm, tR (min): minor = 5.11, 
major = 5.66. 
AnN
NBoc
OMe
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tert-butyl (S)-6-allyl-6-benzyl-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1-carboxylate (4e) 
Prepared according to the general procedure with allyl ester 3e (52.3 mg, 0.100 mmol, 1.0 
equiv), Pd2(dba)3 (3.7 mg, 0.004 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (5.9 mg, 0.01 
mmol, 10 mol %). Purified by silica gel flash chromatography (20% EtOAc/hexanes) to provide 
benzyl diazepanone 4e as a colorless oil (48.1 mg, 0.100 mmol, >99% yield, 89% ee); 1H NMR 
(400 MHz, CDCl3) δ 7.51 – 7.44 (m, 2H), 7.32 – 7.20 (m, 3H), 7.18 – 7.09 (m, 2H), 6.87 – 6.81 
(m, 2H), 5.93 (br s, 1H), 5.26 – 5.12 (m, 2H), 4.09 – 3.88 (m, 2H), 3.84 (s, 3H), 3.78 – 2.41 (m, 
8H), 1.48 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 179.0, 174.6, 162.6, 156.0, 155.4, 136.7, 
133.1, 130.8, 130.5, 128.5, 128.2, 127.0, 119.9, 119.6, 113.7, 80.9, 80.7, 55.5, 54.2, 53.8, 49.1, 
47.5, 47.3, 42.4, 42.0, 41.2, 40.9, 40.0, 28.5; IR (Neat Film, NaCl) 3374, 2974, 2927, 1694, 
1604, 1581, 1510, 1454, 1416, 1392, 1365, 1320, 1282, 1256, 1211, 1166, 1028, 979, 925, 838, 
762, 742, 705, 678, 636, 610 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C28H35N2O5 
[M+H]+: 479.2540, found 479.2533; [α]D22.81 +19.02 (c 1.0, CHCl3); SFC Conditions: 20% IPA, 
2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 3.94, major = 6.20. 
AnN
NBoc
O Bn
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tert-butyl (S)-6-allyl-6-(2-chloroallyl)-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1-
carboxylate (4f) 
Prepared according to the general procedure with allyl ester 3f (48.1 mg, 0.0949 mmol, 1.0 
equiv), Pd2(dba)3 (3.7 mg, 0.004 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (5.9 mg, 0.01 
mmol, 10 mol %). Purified by silica gel flash chromatography (20% EtOAc/hexanes) to provide 
alkenyl chloride 4f as a colorless oil (36.7 mg, 0.0793 mmol, 84% yield, 90% ee); 1H NMR (400 
MHz, CDCl3) δ 7.55 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 5.93 – 5.71 (m, 1H), 5.36 – 
5.07 (m, 4H), 4.36 – 3.84 (m, 4H), 3.83 (s, 3H), 3.82 – 3.51 (m, 2H), 3.00 – 2.33 (m, 4H), 1.50 
(s, 9H); 13C NMR (100 MHz, CDCl3) δ 178.2, 174.6, 162.7, 155.8, 155.2, 137.5, 132.9, 130.5, 
128.3, 120.1, 118.2, 113.7, 81.1, 80.9, 55.5, 52.6, 49.2, 47.7, 47.4, 47.0, 44.5, 43.8, 42.8, 42.0, 
41.8, 40.3, 28.5; IR (Neat Film, NaCl) 2976, 2930, 1694, 1631, 1604, 1580, 1510, 1456, 1421, 
1393, 1366, 1320, 1282, 1256, 1212, 1167, 1150, 1030, 980, 928, 840, 765, 682, 636, 610 cm–1; 
HRMS (MM: ESI-APCI): m/z calc’d for C24H32ClN2O5 [M+H]+: 463.1994, found 463.2005; 
AnN
NBoc
O
Cl
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[α]D22.68 –24.10 (c 0.5, CHCl3); SFC Conditions: 20% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): minor = 2.52, major = 2.77. 
 
 
tert-butyl (S)-6-allyl-4-benzoyl-6-fluoro-5-oxo-1,4-diazepane-1-carboxylate (4g) 
Prepared according to the general procedure with allyl ester 3g (43.2 mg, 0.103 mmol, 1.0 
equiv), Pd2(pmdba)3 (4.4 mg, 0.004 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (5.9 mg, 0.01 
mmol, 10 mol %). Purified by silica gel flash chromatography (20% EtOAc/hexanes) to provide 
alkyl fluoride 4g as a white, amorphous solid (32.6 mg, 0.0866 mmol, 84% yield, 90% ee); 1H 
NMR (400 MHz, CDCl3) δ 7.61 – 7.53 (m, 2H), 7.53 – 7.45 (m, 1H), 7.45 – 7.34 (m, 2H), 5.94 – 
5.72 (m, 1H), 5.34 – 5.17 (m, 2H), 4.58 – 4.38 (m, 1H), 4.26 – 4.02 (m, 2H), 3.99 – 3.74 (m, 
1H), 3.39 – 3.10 (m, 2H), 2.96 – 2.74 (m, 1H), 2.73 – 2.43 (m, 1H), 1.47 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 173.9, 173.9 (d, JC-F = 26.3 Hz), 155.1, 135.2, 132.1, 130.3, 128.4, 128.2, 121.0, 
97.7 (dd, JC-F = 193.9, 47.2 Hz), 81.1, 49.8 (dd, JC-F = 35.3, 23.1 Hz), 47.2, 46.6, 42.6, 39.7 (dd, 
JC-F = 27.6, 21.9 Hz), 28.3; IR (Neat Film, NaCl) 2978, 2926, 1694, 1450, 1414, 1393, 1367, 
BzN
NBoc
O F
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1329, 1246, 1152, 1042, 999, 979, 926, 857, 766, 724, 694, 672, 648 cm–1; HRMS (MM: ESI-
APCI): m/z calc’d for C20H29FN3O4 [M+NH4]+: 438.2035, found 438.2040; [α]D22.85 +28.89 (c 
1.0, CHCl3); SFC Conditions: 10% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR 
(min): minor = 6.26, major = 4.99. 
 
 
 
tert-butyl (S)-6-allyl-6-fluoro-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1-carboxylate (4h) 
Prepared according to the general procedure with allyl ester 3h (60 mg, 0.133 mmol, 1.0 equiv), 
Pd2(dba)3 (4.9 mg, 0.0053 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (7.9 mg, 0.013 mmol, 10 
mol %). Purified by automated silica gel flash chromatography (0→50% acetone/hexanes) to 
provide alkyl fluoride 4h as a colorless oil (45 mg, 0.111 mmol, 84% yield, 83% ee); 1H NMR 
(400 MHz, CDCl3) δ 7.61 – 7.53 (m, 2H), 6.92 – 6.84 (m, 2H), 5.93 – 5.78 (m, 1H), 5.30 – 5.21 
(m, 2H), 4.35 (t, J = 16.0 Hz, 1H), 4.22 – 4.02 (m, 2H), 3.96 – 3.85 (m, 1H), 3.84 (s, 3H), 3.40 – 
3.19 (m, 2H), 2.94 – 2.78 (m, 1H), 2.71 – 2.48 (m, 1H), 1.47 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 173.9, 173.7, 163.1, 155.3, 131.0, 130.6, 127.1, 121.0, 113.8, 97.8 (dd, JC-F = 193.7, 
AnN
NBoc
O F
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 	
 
S12 
52.5 Hz), 81.2, 55.5, 49.8 (dd, JC-F = 33.5, 23.3 Hz), 47.5, 46.9, 43.2, 39.8 (dd, JC-F = 32.1, 21.8 
Hz), 28.3; IR (Neat Film, NaCl) 2977, 2932, 1696, 1603, 1578, 1511, 1448, 1413, 1366, 1327, 
1256, 1169, 1152, 1029, 1000, 977, 923, 835, 766 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for 
C21H28FN2O5 [M+H]
+: 407.1977, found 407.1973; [α]D22.5 +46.99 (c 1.7, CHCl3); SFC 
conditions: 20% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): major = 2.69, 
minor = 3.25. 
 
 
 
tert-butyl (S)-6-allyl-4-(4-methoxybenzoyl)-5-oxo-6-(prop-2-yn-1-yl)-1,4-diazepane-1-
carboxylate (4i) 
Prepared according to the general procedure with allyl ester 3i (70.0 mg, 0.149 mmol, 1.0 equiv), 
Pd2(pmdba)3 (5.4 mg, 4.9 µmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (8.8 mg, 0.015 mmol, 10 
mol %) at 50 °C. Purification by automated silica gel flash chromatography (Teledyne ISCO, 
0→40% acetone/hexanes) provided alkyne 4i as a colorless oil (28.0 mg, 0.0656 mmol, 44% 
AnN
NBoc
O
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yield, 94% ee); 1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.2 Hz, 2H), 6.89 – 6.82 (m, 2H), 
5.93 – 5.63 (m, 1H), 5.30 – 5.10 (m, 2H), 4.36 – 4.15 (m, 1H), 4.09 – 3.68 (m, 4H), 3.83 (s, 3H), 
3.62 – 3.37 (m, 1H), 2.83 – 2.43 (m, 4H), 2.20 – 1.99 (m, 1H), 1.51 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 177.5, 174.6, 162.9, 155.6, 155.2, 132.1, 130.7, 127.9, 120.0, 113.7, 81.1, 80.9, 
80.5, 72.1, 55.6, 52.7, 49.1, 46.9, 47.7, 43.0, 42.3, 39.1, 37.5, 28.5, 26.5, 25.9; IR (Neat Film, 
NaCl) 3283, 2972, 2922, 1692, 1603, 1511, 1454, 1418, 1365, 1322, 1255, 1169, 1031, 980, 926, 
839, 766, 670 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C24H31N2O5 [M+H]
+: 427.2227, 
found 427.2238; [α]D22.1
 
–7.69 (c 1.0, CHCl3); SFC conditions: 10% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 210 nm, tR (min): major = 10.85, minor = 10.29. 
 
 
tert-butyl (R)-6-allyl-6-(3-methoxy-3-oxopropyl)-4-(4-methoxybenzoyl)-5-oxo-1,4-
diazepane-1-carboxylate (4j) 
AnN
NBoc
O
CO2Me
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Prepared according to the general procedure with allyl ester 3j (51.9 mg, 0.100 mmol, 1.0 equiv), 
Pd2(dba)3 (3.7 mg, 0.004 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (5.9 mg, 0.01 mmol, 10 
mol %). Purified by silica gel flash chromatography (33% EtOAc/hexanes) to provide methyl 
ester 4j as a white, amorphous solid (45.8 mg, 0.0965 mmol, 96% yield, 95% ee);	 1H NMR (400 
MHz, CDCl3) δ 7.57 – 7.48 (m, 2H), 6.92 – 6.83 (m, 2H), 5.80 – 5.64 (m, 1H), 5.22 – 5.09 (m, 
2H), 4.21 (ddd, J = 15.7, 6.6, 2.1 Hz, 1H), 4.13 – 3.85 (m, 3H), 3.83 (s, 3H), 3.62 (s, 3H), 3.51 
(d, J = 15.2 Hz, 1H), 3.42 – 3.29 (m, 1H), 2.64 – 2.20 (m, 4H), 2.20 – 1.86 (m, 2H), 1.49 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 179.2, 174.7, 173.6, 173.4, 162.7, 155.4, 155.0, 132.7, 132.5, 
130.3, 128.3, 120.0, 113.8, 81.1, 80.9, 55.5, 51.8, 50.1, 48.9, 47.6, 46.8, 43.2, 42.9, 40.3, 39.7, 
29.3, 28.8, 28.5; IR (Neat Film, NaCl) 2975, 2360, 1736, 1694, 1605, 1580, 1510, 1426, 1393, 
1366, 1321, 1283, 1254, 1167, 1031, 980, 927, 842, 811, 762, 647, 610 cm–1; HRMS (MM: ESI-
APCI): m/z calc’d for C25H35N2O7 [M+H]+: 475.2439, found 475.2438; [α]D22.52
 
+7.73 (c 1.0, 
CHCl3); SFC conditions: 15% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): 
major = 5.27, minor = 4.84. 
 
 
AnN
NBoc
O
CN
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tert-butyl (R)-6-allyl-6-(2-cyanoethyl)-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1-
carboxylate (4k) 
Prepared according to the general procedure with allyl ester 3k (62.2 mg, 0.128 mmol, 1.0 
equiv), Pd2(dba)3 (4.7 mg, 0.00512 mmol, 4 mol %), and (S)-(CF3)3-t-BuPHOX (7.6 mg, 0.0128 
mmol, 10 mol %), using 9:1 methylcyclohexane-toluene as the reaction solvent. Purified by 
silica gel flash chromatography (33% EtOAc/hexanes) to provide nitrile 4k as a white, 
amorphous solid (48.6 mg, 0.110 mmol, 86% yield, 84% ee); 1H NMR (400 MHz, CDCl3) δ 7.59 
– 7.47 (m, 2H), 6.96 – 6.85 (m, 2H), 5.82 – 5.64 (m, 1H), 5.30 – 5.11 (m, 2H), 4.09 – 3.93 (m, 
2H), 3.93 – 3.72 (m, 2H), 3.85 (s, 3H), 3.70 – 3.38 (m, 2H), 2.60 – 2.25 (m, 4H), 2.22 – 1.93 (m, 
2H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 178.0, 174.5, 163.0, 155.6, 154.9, 131.7, 
130.3, 127.9, 120.7, 119.7, 113.9, 81.4, 55.6, 52.2, 49.6, 48.0, 47.4, 46.8, 43.0, 42.6, 39.9, 39.0, 
32.1, 31.5, 28.4, 12.4; IR (Neat Film, NaCl) 2975, 2931, 2361, 2246, 1690, 1604, 1579, 1510, 
1456, 1419, 1366, 1321, 1256, 1168, 1148, 1031, 980, 926, 840, 811, 766, 607 cm–1; HRMS 
(MM: ESI-APCI): m/z calc’d for C24H35N4O5 [M+NH4]+: 459.2602, found 459.2602; [α]D22.4
 
+9.31 (c 0.5, CHCl3); SFC conditions: 20% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 310 
nm, tR (min): major = 8.33, minor = 6.18. 
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tert-butyl (S)-6-allyl-4-benzoyl-6-(((tert-butoxycarbonyl)amino)methyl)-5-oxo-1,4-
diazepane-1-carboxylate (4l) 
Prepared according to the general procedure with allyl ester 3l (53 mg, 0.0997 mmol, 1.0 equiv) 
and Pd2(dba)3. Purification by automated silica gel flash chromatography (0→50% 
EtOAc/hexanes) provided carbamate 4l as a white foam (37 mg, 0.0759 mmol, 76% yield, 93% 
ee). 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.44 (m, 3H), 7.44 – 7.35 (m, 2H), 5.74 (ddt, J = 15.7, 
10.5, 7.4 Hz, 1H), 5.35 (br s, 0.5H), 5.21 – 5.06 (m, 2H), 4.79 (br s, 0.5H), 4.48 – 4.28 (m, 1H), 
4.14 – 3.09 (m, 7H), 2.69 – 2.18 (m, 2H), 1.50 (s, 9H), 1.44 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 179.3, 178.8, 174.5, 156.3, 155.9, 155.1, 136.3, 132.5, 132.1, 131.7, 128.5, 127.7, 
120.1, 81.3, 81.1, 79.5, 54.8, 48.9, 47.3, 46.8, 46.3, 42.6, 41.1, 38.7, 37.1, 28.5, 28.5; IR (Neat 
Film, NaCl) 2977, 1687, 1502, 1422, 1391, 1365, 1322, 1282, 1245, 1168, 978, 916, 753 cm–1; 
HRMS (MM: ESI-APCI): m/z calc’d for C26H37N3O6 [M+H]
+: 488.2755, found 488.2747; 
[α]D23.2 –3.70 (c 1.85, CHCl3); SFC conditions: 20% IPA, 2.5 mL/min, Chiralpak IC column, λ = 
254 nm, tR (min): major = 5.85, minor = 4.65. 
BzN
NBoc
O
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Procedure for the large scale preparation of diazepanone 4e 
To a 500 mL Schlenk flask was added Pd2(dba)3 (37 mg, 0.04 mmol, 4 mol %), (S)-(CF3)3-t-
BuPHOX (59 mg, 0.1 mmol, 10 mol %), and MeCy (20 mL). After stirring for 20 minutes at 25 
°C, allyl ester 3e (523 mg, 1.0 mmol, 1.0 equiv) and methylcyclohexane (52 mL, total substrate 
concentration 0.014 M) were added to the pre-stirred catalyst solution. After stirring for 23 h at 
40 °C, the reaction mixture was directly loaded onto a flash column and purified by silica gel 
flash chromatography (20% EtOAc/hexanes) to provide benzyl diazepanone 4e as a colorless oil 
(393 mg, 0.82 mmol, 82% yield, 83% ee); All characterization data matched those reported 
above for compound 4e; [α]D21.96 +14.757 (c 1.0, CHCl3); SFC Conditions: 20% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 3.76, major = 5.90. 
 
AnN
NBoc
O Bn
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Synthesis of Allylic Alkylation Substrates 
 
tert-butyl 4-benzoyl-5-oxo-1,4-diazepane-1-carboxylate (SI1) 
To a solution of tert-butyl 5-oxo-1,4-diazepane-1-carboxylate (5.00 g, 23.3 mmol, 1.0 equiv) in 
THF (230 mL, 0.1 M) at –78 °C was slowly added n-BuLi (2.18 M in hexanes, 12.8 mL, 27.9 
mmol, 1.2 equiv). The opaque mixture was allowed to warm to ambient temperature until the 
solution became homogeneous, at which point it was again cooled to –78 °C. Then, benzoyl 
chloride (3.52 mL, 30.3 mmol, 1.3 equiv) was added dropwise and the reaction turned light 
orange over several minutes. The reaction was stirred for 1 h at –78 °C, then poured into 
saturated aqueous NH4Cl (200 mL) and extracted with EtOAc (3 x 100 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated. The crude product was purified by 
silica gel flash chromatography (20% acetone/hexanes) to afford benzoyl-protected lactam SI1 
as a white solid (7.43 g, 23.3 mmol, >99% yield); 1H NMR (400 MHz, CDCl3) δ 7.57 – 7.49 (m, 
2H), 7.49 – 7.41 (m, 1H), 7.41 – 7.32 (m, 2H), 4.03 – 3.96 (m, 2H), 3.71 (m, 4H), 2.82 – 2.75 
(m, 2H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 175.6, 173.7, 154.5, 135.9, 131.7, 128.2, 
127.9, 80.7, 47.8, 47.10, 45.4, 41.6, 41.0, 40.6, 28.3; IR (Neat Film, NaCl) 2976, 2932, 2251, 
1682, 1599, 1582, 1450, 1422, 1392, 1366,1327, 1285, 1247, 1229, 1157, 1115, 1032, 1018, 976, 
954, 915,862, 793,769, 729, 696, 647 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C17H26N3O4 
[M+NH4]
+: 336.1918, found 336.1912. 
 
tert-butyl 5-oxo-4-(4-(trifluoromethyl)benzoyl)-1,4-diazepane-1-carboxylate (SI2) 
BzN
NBoc
O
(p-F3C-Bz)N
NBoc
O
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To a solution of tert-butyl 5-oxo-1,4-diazepane-1-carboxylate (500 mg, 2.33 mmol, 1 equiv) in 
THF (25 mL, 0.1 M) at –78 °C was slowly added n-BuLi (2.5 M in hexanes, 1.02 mL, 2.56 
mmol, 1.1 equiv), and the reaction mixture was stirred at –78 °C for 15 min. Then, 4-
trifluoromethylbenzoyl chloride (450 µL, 3.03 mmol, 1.3 equiv) was added dropwise, and the 
reaction was stirred for 30 min at –78 °C. The reaction mixture was then poured into saturated 
aqueous NH4Cl (20 mL), the layers were separated, and the aqueous layer was extracted with 
EtOAc (3 x 10 mL). The combined organic extracts were dried over Na2SO4 and concentrated 
under reduced pressure. The crude product was purified by silica gel flash chromatography (25% 
EtOAc/hexanes) to afford the title compound as a white solid (698 mg, 1.81 mmol, 77% yield); 
1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 8.2 Hz, 2H), 7.60 (d, J = 8.1 Hz, 2H), 4.14 – 4.02 (m, 
2H), 3.84 – 3.66 (m, 4H), 2.91 – 2.77 (m, 2H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
175.7, 172.5, 154.6, 139.6, 133.0 (q, JC-F = 32.8 Hz), 130.6, 128.0, 125.5 (q, JC-F = 3.8 Hz), 
123.7 (q, JC-F = 272.6 Hz), 81.2, 47.7 (br), 45.3, 41.4 (br), 40.8, 28.5; IR (Neat Film, NaCl) 2981, 
1689, 1455, 1422, 1367, 1326, 1301, 1249, 1230, 1159, 1127, 1066, 1028, 1015, 977, 955, 852, 
832, 769 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C18H25F3N3O4 [M+NH4]+: 404.1742, 
found 404.1797. 
 
tert-butyl 4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1-carboxylate (SI3) 
To a solution of tert-butyl 5-oxo-1,4-diazepane-1-carboxylate (800 mg, 3.73 mmol, 1 equiv) in 
THF (37 mL, 0.1 M) at –78 °C was slowly added n-BuLi (2.5 M in hexanes, 1.64 mL, 4.1 mmol, 
1.1 equiv). The opaque mixture was allowed to warm to ambient temperature until the solution 
became homogeneous, at which point it was again cooled to –78 °C. Then, 4-methoxybenzoyl 
chloride (657 µL, 4.85 mmol, 1.3 equiv) was added dropwise and the reaction was stirred for 30 
min at –78 °C. The reaction mixture was then poured into saturated aqueous NH4Cl (30 mL), the 
layers were separated, and the aqueous layer was extracted with EtOAc (3 x 10 mL). The 
combined organic extracts were dried over Na2SO4 and concentrated under reduced pressure. 
The crude product was purified by automated silica gel flash chromatography (Teledyne ISCO, 
0→100% EtOAc/hexanes) to afford the title compound as a white solid (1.2 g, 3.44 mmol, 92% 
AnN
NBoc
O
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yield); 1H NMR (400 MHz, CDCl3) δ 7.62 – 7.54 (m, 2H), 6.93 – 6.84 (m, 2H), 4.00 – 3.93 (m, 
2H), 3.83 (s, 3H), 3.78 – 3.69 (m, 4H), 2.85 – 2.78 (m, 2H), 1.48 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 175.7, 173.4, 162.9, 154.6, 130.9, 130.6, 127.7, 113.7, 80.8, 55.5, 48.0, 47.4, 46.1, 
41.9, 41.3, 40.8, 28.5; IR (Neat Film, NaCl) 2974, 2936, 1774, 1687, 1604, 1578, 1510, 1458, 
1420, 1391, 1366, 1327, 1284, 1249, 1166, 1114, 1023, 977, 956, 916, 860, 842, 809, 767, 632 
cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C18H25N2O5 [M+H]
+: 349.1758, found 349.1760. 
 
6-allyl 1-(tert-butyl) 4-benzoyl-5-oxo-1,4-diazepane-1,6-dicarboxylate (2a) 
To a solution of diisopropylamine (266 µL, 1.88 mmol, 1.2 equiv) in THF (10 mL) at –78 °C in a 
flame-dried round-bottom flask was added n-BuLi (2.5 M in hexanes, 792 µL, 1.73 mmol, 1.1 
equiv), the resulting solution was stirred at –78 °C for 45 min. To this solution was then added 
lactam SI1 (500 mg, 1.57 mmol, 1.0 equiv) in THF (6 mL, 0.1 M total concentration) dropwise 
while stirring at −78 °C. The reaction mixture was stirred for 75 min at −78 °C. Allyl 
cyanoformate (201 µL, 1.88 mmol, 1.2 equiv) was then added dropwise at −78 °C. After stirring 
for 3 h at −78 °C, the reaction mixture was poured into saturated aqueous NH4Cl (10 mL) and 
extracted with ethyl acetate (3 x 20 mL). The combined organic extracts were concentrated under 
reduced pressure onto silica (4 g). The silica-adsorbed crude mixture was purified by silica gel 
flash chromatography (20→30% EtOAc/hexanes) to provide allyl ester 2a as an off-white solid 
(550 mg, 1.37 mmol, 87% yield); 1H NMR (500 MHz, CDCl3) δ 7.65 – 7.57 (m, 2H), 7.53 – 7.45 
(m, 1H), 7.42 – 7.34 (m, 2H), 5.92 (ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.40 – 5.22 (m, 2H), 4.79 – 
4.59 (m, 2H), 4.33 – 4.03 (m, 2H), 4.02 – 3.88 (m, 3H), 3.87 – 3.66 (m, 1H), 3.55 – 3.40 (m, 
1H), 1.48 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 173.7, 171.4, 167.5, 154.7, 135.3, 132.2, 
131.4, 128.4, 128.4, 119.5, 81.3, 66.6, 56.0, 46.7 (br), 44.5, 43.3 (br), 28.4; IR (Neat Film, NaCl) 
3374, 3062, 2977, 2934, 1746, 1694, 1600, 1582, 1450, 1419, 1393, 1367, 1327, 1246, 1156, 
1037, 1020, 995, 968, 939, 857, 792, 769, 727, 695, 616 cm–1; HRMS (MM: ESI-APCI): m/z 
calc’d for C21H30N3O6 [M+NH4]
+: 420.2129, found 420.2109. 
BzN
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6-allyl 1-(tert-butyl) 5-oxo-4-(4-(trifluoromethyl)benzoyl)-1,4-diazepane-1,6-dicarboxylate 
(2b) 
To a solution of lactam SI2 (500 mg, 1.29 mmol, 1.0 equiv) in THF (8 mL, 0.1 M total 
concentration) at −78 °C was added LiHMDS (303 mg, 1.81 mmol, 1.4 equiv) in THF (5 mL) 
dropwise. The resulting yellow reaction mixture was stirred for 15 min at −78 °C. Then, allyl 
cyanoformate (166 µL, 1.55 mmol, 1.2 equiv) was added dropwise at −78 °C, after which the 
solution slowly became colorless. After stirring for 1 h at −78 °C, the reaction was poured into 2 
M HCl (20 mL) and extracted with ethyl acetate (4 x 20 mL). The combined organic extracts 
were dried over anhydrous Na2SO4 and NaHCO3, passed through filter paper, and concentrated 
under reduced pressure. The crude product was purified by silica gel flash chromatography 
(20→33% EtOAc/hexanes) to provide allyl ester 2b as a white solid (266 mg, 0.565 mmol, 44% 
yield); 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.3 Hz, 2H), 7.64 (d, J = 8.4 Hz, 2H), 5.92 
(ddt, J = 17.2, 10.4, 5.9 Hz, 1H), 5.42 – 5.23 (m, 2H), 4.79 – 4.59 (m, 2H), 4.46 – 3.63 (m, 6H), 
3.52 (m, 1H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.4, 171.4, 167.4, 154.6, 138.9, 
133.3 (q, JC-F = 32.6 Hz), 131.2, 128.3, 125.4 (q, JC-F = 3.8 Hz), 123.7 (q, JC-F = 272.5 Hz), 
119.8, 81.5, 66.8, 56.0, 47.4, 46.3, 44.2, 43.0, 28.4; IR (Neat Film, NaCl) 3377, 3083, 2980, 
2935, 2463, 2358, 1928, 1798, 1747, 1694, 1652, 1619, 1584, 1513, 1455, 1414, 1394, 1368, 
1327, 1246, 1156, 1131, 1067, 1034, 1016, 994, 970, 940, 879, 853, 824, 770, 723, 679, 639, 
630, 612 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C22H29F3N3O6 [M+NH4]+: 488.2003, 
found 488.2022. 
 
6-allyl 1-(tert-butyl) 4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1,6-dicarboxylate (2c) 
To a solution of lactam SI3 (1.00 g, 2.87 mmol, 1.0 equiv) in THF (20 mL, 0.1 M total 
concentration) at −78 °C was added LiHMDS (528 mg, 3.16 mmol, 1.1 equiv) in THF (9 mL) 
(p-F3C-Bz)N
NBoc
O
O
O
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dropwise. The resulting pale yellow reaction mixture was stirred for 15 min at −78 °C. Allyl 
cyanoformate (368 µL, 3.44 mmol, 1.2 equiv) was then added dropwise at −78 °C, resulting in a 
clear solution. After stirring for 1.5 h at −78 °C, the reaction was poured into 1 M HCl (10 mL) 
and diluted with ethyl acetate (20 mL). The layers were separated and the aqueous phase was 
extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were dried over 
anhydrous Na2SO4 and NaHCO3, filtered, and concentrated under reduced pressure onto silica. 
The silica-adsorbed crude mixture was purified by silica gel flash chromatography (10→20% 
EtOAc/hexanes) to provide allyl ester 2c as a colorless oil (600 mg, 1.39 mmol, 48% yield); 1H 
NMR (400 MHz, CDCl3) δ 7.72 – 7.60 (m, 2H), 6.91 – 6.79 (m, 2H), 5.92 (ddt, J = 17.3, 10.4, 
5.9 Hz, 1H), 5.42 – 5.20 (m, 2H), 4.77 – 4.56 (m, 2H), 4.40 – 3.92 (m, 4H), 3.92 – 3.62 (m, 2H), 
3.82 (s, 3H), 3.58 – 3.24 (m, 1H), 1.46 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 173.1, 171.3, 
167.6, 163.2, 154.6, 131.4, 131.2, 127.0, 119.4, 113.7, 81.1, 66.5, 55.9, 55.4, 47.7 and 46.7, 45.1, 
43.3, 42.8, 28.3; IR (Neat Film, NaCl) 2977, 1746, 1693, 1603, 1578, 1511, 1454, 1419, 1392, 
1366, 1324, 1255, 1168, 1025, 995, 965, 842, 766 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for 
C22H28N2O7 [M+H]
+: 433.1969, found 433.1966. 
 
6-allyl 1-(tert-butyl) 4-benzoyl-6-benzyl-5-oxo-1,4-diazepane-1,6-dicarboxylate (3a) 
To a flame-dried round bottom flask containing a solution of allyl ester 2a (1.00 g, 2.49 mmol, 
1.0 equiv) in THF (25 mL, 0.1 M) at 0 °C was added NaH (60% dispersion in mineral oil, 107 
mg, 2.74 mmol, 1.1 equiv) and the mixture was stirred at 0 °C for 30 min. BnBr (1.50 mL, 12.45 
mmol, 5.0 equiv) was then added dropwise and the reaction mixture was warmed to 45 °C. After 
16 h, the temperature was further increased to 53 °C due to sluggish reactivity. After another 45 
min of stirring at 53 °C, the reaction mixture was cooled to 23 °C and poured into saturated 
aqueous NH4Cl (25 mL), the layers were separated, and the aqueous layer was extracted with 
ethyl acetate (3 x 10 mL). The combined organic extracts were dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The crude product was purified by silica gel 
flash chromatography (20% EtOAc/hexanes) to provide the title compound as a colorless foam 
(922 mg, 1.87 mmol, 75% yield);	 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 7.6 Hz, 2H), 7.55 – 
BzN
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7.46 (m, 1H), 7.37 (t, J = 7.7 Hz, 2H), 7.31 – 7.25 (m, 3H), 7.24 – 7.12 (m, 2H), 5.86 (tq, J = 
22.8, 6.5 Hz, 1H), 5.42 – 5.26 (m, 2H), 4.71 – 4.55 (m, 2H), 4.22 (dd, J = 75.3, 15.5 Hz, 1H), 
4.05 – 3.57 (m, 4H), 3.57 – 3.36 (m, 2H), 3.22 (dd, J = 68.5, 13.7 Hz, 1H), 1.45 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ (174.4, 174.0, 172.2, 172.0, 170.8, 170.2, 155.5, 155.0, 135.7, 135.6, 
135.5, 132.0, 131.1, 130.9, 130.8, 130.6, 128.5, 128.5, 128.3, 127.5, 127.4, 120.6, 120.2, 81.2, 
81.0, 67.0, 66.9, 62.6, 62.2, 47.3, 46.7, 46.2, 45.8, 42.4, 42.1, 42.0, 28.5; IR (Neat Film, NaCl) 
3063, 3030, 2977, 2933, 1694, 1601, 1583, 1495, 1450, 1416, 1393, 1366, 1325, 1280, 1247, 
1154, 1132, 1092, 1041, 1023, 980, 939, 868, 796, 768, 728, 703, 662 cm–1; HRMS (MM: ESI-
APCI): m/z calc’d for C24H25N2O6 [M–tBu+2H]+: 437.1707, found 437.1697. 
 
6-allyl 1-(tert-butyl) 4-benzoyl-6-methyl-5-oxo-1,4-diazepane-1,6-dicarboxylate (3b) 
To a solution of allyl ester 2a (240 mg, 0.596 mmol, 1.0 equiv) in THF (6 mL, 0.1 M) at 0 °C 
was added 60 % NaH (26 mg, 0.657 mmol, 1.1 equiv). The solution was stirred at 0 °C for 40 
min, after which MeI (186 µL, 2.98 mmol, 5.0 equiv) was added rapidly. The reaction was 
heated to 45 °C and stirred for 16 h, cooled to 23 °C, poured into saturated aqueous NH4Cl (5 
mL), and extracted with EtOAc (3 x 3 mL). The combined organic extracts were dried over 
Na2SO4 and concentrated onto silica gel. The silica-adsorbed crude product was purified by silica 
gel flash chromatography (20% EtOAc/hexanes) to afford the title compound as a light yellow 
oil (200 mg, 0.480 mmol, 81% yield). 1H NMR (400 MHz, CDCl3) δ 7.78 – 7.63 (m, 2H), 7.58 – 
7.43 (m, 1H), 7.38 (t, J = 7.6 Hz, 2H), 5.96 (ddt, J = 16.6, 10.4, 6.0 Hz, 1H), 5.49 – 5.26 (m, 
2H), 4.85 – 4.64 (m, 2H), 4.46 – 4.22 (m, 1H), 4.10 (br d, J = 14.8 Hz, 1H), 3.86 – 3.42 (m, 4H), 
1.57 (s, 3H), 1.45 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 174.5 174.1, 173.0, 171.7, 155.1, 
154.9, 135.7, 132.0, 131.2, 128.3, 128.2, 120.2, 81.1, 66.9, 57.7, 49.8, 49.0, 47.1, 46.0, 43.2, 
28.4, 23.6; IR (Neat Film, NaCl) 2977, 1693, 1449, 1416, 1366, 1325, 1281, 1249, 1139, 1104, 
1047, 983, 938, 768, 727, 694 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C22H29N2O6 
[M+H]+: 417.2020, found 417.2010. 
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6-allyl 1-(tert-butyl) 6-methyl-5-oxo-4-(4-(trifluoromethyl)benzoyl)-1,4-diazepane-1,6-
dicarboxylate (3c) 
To a suspension of allyl ester 2b (150 mg, 0.319 mmol, 1.0 equiv) and Cs2CO3 (208 mg, 0.638 
mmol, 2.0 equiv) in acetonitrile (3.2 mL, 0.1 M) was added MeI (99 µL, 1.59 mmol, 5.0 equiv) 
at 23 °C. The reaction was heated to 45 °C and stirred for 5 h, then cooled to 23 °C, poured into 
saturated aqueous NH4Cl (6 mL), and extracted with EtOAc (3 x 3 mL). The combined organic 
extracts were dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. 
The crude product was purified by silica gel flash chromatography (15% EtOAc/petroleum ether) 
to provide the title compound as a colorless oil (146 mg, 0.301 mmol, 95% yield); 1H NMR (400 
MHz, CDCl3) δ 7.75 (d, J = 8.1 Hz, 2H), 7.63 (d, J = 8.1 Hz, 2H), 5.97 (ddt, J = 17.3, 10.3, 6.1 
Hz, 1H), 5.48 – 5.29 (m, 2H), 4.84 – 4.68 (m, 2H), 4.49 – 4.30 (m, 1H), 4.18 – 3.98 (m, 1H), 
3.90 – 3.39 (m, 4H), 1.57 (s, 3H), 1.45 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 173.2, 172.7, 
171.7, 154.9, 139.2, 133.1 (q, JC-F = 32.5 Hz), 131.1, 128.2, 125.4, 123.8 (q, JC-F = 272.7 Hz), 
120.5, 81.3, 67.0, 57.7, 49.7, 49.0, 46.9, 45.8, 43.1, 42.9, 28.4, 23.7; IR (Neat Film, NaCl) 3384, 
3083, 2979, 2937, 1698, 1619, 1584, 1514, 1478, 1453, 1416, 1394, 1367, 1326, 1285, 1250, 
1207, 1166, 1136, 1110, 1066, 1022, 1012, 985, 938, 855, 832, 817, 790, 769, 740, 722, 680 cm–
1; HRMS (MM: ESI-APCI): m/z calc’d for C23H28F3N2O6 [M+H]+: 485.1894, found 485.1907. 
 
6-allyl 1-(tert-butyl) 4-(4-methoxybenzoyl)-6-methyl-5-oxo-1,4-diazepane-1,6-dicarboxylate 
(3d) 
To a suspension of allyl ester 2c (200 mg, 0.462 mmol, 1.0 equiv), Cs2CO3 (301 mg, 0.925 
mmol, 2.0 equiv) in acetonitrile (4.6 mL, 0.1 M) was added MeI (143 µL, 2.31 mmol, 5.0 equiv) 
at 23 °C. The reaction was heated to 45 °C and stirred for 40 min, then cooled to 23 °C, poured 
(p-F3C-Bz)N
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into saturated aqueous NH4Cl (10 mL), and extracted with EtOAc (3 x 5 mL). The combined 
organic extracts were dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure. The crude product was purified by automated silica gel flash chromatography 
(Teledyne ISCO, 0→90% EtOAc/hexanes) to provide the title compound as a colorless oil (70 
mg, 0.157 mmol, 34% yield). 1H NMR (400 MHz, CDCl3) δ 7.75 – 7.65 (m, 2H), 6.90 – 6.82 (m, 
2H), 5.96 (ddt, J = 17.3, 10.4, 6.0 Hz, 1H), 5.44 – 5.29 (m, 2H), 4.77 – 4.66 (m, 2H), 4.27 – 4.15 
(m, 1H), 4.14 – 4.04 (m, 1H), 3.83 (s, 3H), 3.80 – 3.70 (m, 1H), 3.67 – 3.58 (m, 2H), 3.56 – 3.46 
(m, 1H), 1.57 (s, 3H), 1.44 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 174.0, 173.6, 172.9, 172.0, 
171.8, 162.9, 155.2, 154.9, 131.2, 131.2, 131.0, 127.6, 120.1, 120.0, 113.6, 81.0, 66.8, 57.5, 55.5, 
49.6, 48.9, 47.2, 46.1, 43.7, 28.4, 23.7; IR (Neat Film, NaCl) 2974, 2937, 1698, 1604, 1578, 
1511, 1453, 1416, 1392, 1366, 1324, 1280, 1256, 1169, 1139, 1103, 1031, 1001, 983, 929, 840, 
768, 733 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C23H31N2O7 [M+H]
+: 447.2126, found 
447.2128. 
 
6-allyl 1-(tert-butyl) 6-benzyl-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1,6-dicarboxylate 
(3e) 
To a flame-dried round bottom flask containing a solution of allyl ester 2c (300 mg, 0.694 mmol, 
1.0 equiv) in THF (7 mL, 0.1 M) at 0 °C was added NaH (60% dispersion in mineral oil, 38 mg, 
0.972 mmol, 1.4 equiv) and the mixture was stirred at 0 °C for 15 min and then allowed to warm 
to 23 °C over 15 min. BnBr (412 µL, 3.47 mmol, 5.0 equiv) was then added dropwise and the 
reaction mixture was heated to 50 °C. After stirring for 8 h, the reaction mixture was allowed to 
cool to 23 °C and poured into saturated aqueous NH4Cl (5 mL), the layers were separated, and 
the aqueous phase was extracted with ethyl acetate (3 x 2 mL). The combined organic extracts 
were dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified by silica gel flash chromatography (20% EtOAc/hexanes) to provide the 
title compound as a colorless foam (303 mg, 0.580 mmol, 84% yield); 1H NMR (500 MHz, 
CDCl3) δ 7.72 (d, J = 8.5 Hz, 2H), 7.31 – 7.12 (m, 5H), 6.90 – 6.80 (m, 2H), 5.95 – 5.75 (m, 1H), 
5.41 – 5.26 (m, 2H), 4.69 – 4.54 (m, 2H), 4.21 – 4.05 (m, 1H), 4.02 – 3.86 (m, 2H), 3.83 (s, 3H), 
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3.78 – 3.62 (m, 2H), 3.56 – 3.49 (m, 1H), 3.43 – 3.10 (m, 2H), 1.45 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 173.7, 173.4, 172.0, 171.7, 170.8, 170.2, 162.9, 155.4, 154.8, 135.7, 135.6, 
131.1, 130.9, 130.7, 130.5, 128.5, 128.3, 128.2, 127.5, 127.3, 127.0, 120.2, 119.9, 113.5, 80.9, 
80.7, 66.6, 62.4, 62.0, 55.3, 47.1, 46.8, 46.0, 45.8, 42.8, 42.5, 41.9, 28.3; IR (Neat Film, NaCl) 
2976, 2359, 1698, 1604, 1512, 1455, 1416, 1366, 1324, 1258, 1155, 1028, 979, 840, 741, 703, 
671, 634 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C29H35N2O7 [M+H]+: 523.2439, found 
523.2446. 
 
6-allyl 1-(tert-butyl) 6-(2-chloroallyl)-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1,6-
dicarboxylate (3f) 
To a suspension of allyl ester 2c (300 mg, 0.694 mmol, 1.0 equiv) and Cs2CO3 (453 mg, 1.39 
mmol, 2.0 equiv) in acetonitrile (7 mL, 0.1 M) was added 2,3-dichloropropene (320 µL, 3.47 
mmol, 5.0 equiv) at 23 °C. The reaction mixture was heated to 50 °C and stirred for 19 h, after 
which starting material remained as judged by TLC. Tetrabutylammonium iodide (25.6 mg, 
0.0694 mmol, 0.1 equiv) was added and the reaction mixture was stirred at 50 °C for an 
additional 9 h, then allowed to cool to 23 °C. The mixture was filtered through a cotton plug and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
chromatography (20% EtOAc/petroleum ether) to provide the title compound as a colorless oil 
(196 mg, 0.387 mmol, 56% yield); 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.8 Hz, 2H), 6.85 
(d, J = 8.9 Hz, 2H), 6.12 – 5.94 (m, 1H), 5.60 – 5.25 (m, 4H), 4.78 (qdt, J = 12.8, 6.0, 1.2 Hz, 
2H), 4.25 (br t, J = 13.9 Hz, 1H), 4.17 – 3.87 (m, 3H), 3.84 (s, 3H), 3.76 – 3.51 (m, 1H), 3.48 – 
3.30 (m, 1H), 3.29 – 2.99 (m, 2H), 1.43 (d, J = 16.9 Hz, 9H); 13C NMR (100 MHz, CDCl3) δ 
173.9, 173.3, 170.3, 163.1, 155.9, 155.1, 137.0, 136.7, 131.1, 127.2, 120.6, 120.3, 119.4, 118.4, 
113.6, 81.4, 81.0, 67.5, 60.0, 55.5, 47.1, 45.9, 46.0, 45.2, 45.6, 44.7, 43.1, 42.8, 28.4; IR (Neat 
Film, NaCl) 3356, 3080, 2977, 2933, 2841, 2568, 2254, 1700, 1629, 1605, 1579, 1512, 1456, 
1417, 1393, 1367, 1326, 1281, 1257, 1217, 1196, 1153, 1029, 988, 910, 842, 811, 780, 757, 732, 
668, 634, 621 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C25H32ClN2O7 [M+H]+: 507.1893, 
found 507.1902. 
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6-allyl 1-(tert-butyl) 4-benzoyl-6-fluoro-5-oxo-1,4-diazepane-1,6-dicarboxylate (3g) 
To a 20 mL vial containing allyl ester 2a (250 mg, 0.621 mmol, 1.0 equiv) in THF (7.4 mL, 0.1 
M) at 23 °C was added NaH (60% dispersion in mineral oil, 27.3 mg, 0.683 mmol, 1.1 equiv). 
After stirring for 12 min, Selectfluor™ (264 mg, 0.745 mmol, 1.2 equiv) was added in a single 
portion, and the reaction mixture was warmed to 50 °C and stirred for 24 h, after which starting 
material remained as judged by TLC. Additional Selectfluor™ (264 mg, 0.745 mmol, 1.2 equiv) 
was then added, and the reaction mixture was stirred for an additional 8 h at 50 °C. The reaction 
mixture was allowed to cool to 23 °C and water (5 mL) was added. The layers were separated 
and the aqueous layer was extracted with EtOAc (3 x 5 mL). The combined organic extracts 
were dried over anhydrous Na2SO4, concentrated under reduced pressure, and purified by silica 
gel flash chromatography (25% EtOAc/hexanes) to provide the title compound (167 mg, 0.397 
mmol, 64% yield); 1H NMR (500 MHz, CDCl3) δ 7.64 – 7.56 (m, 2H), 7.52 – 7.43 (m, 1H), 7.36 
(t, J = 7.7 Hz, 2H), 5.99 – 5.80 (m, 1H), 5.43 – 5.19 (m, 2H), 4.83 – 4.56 (m, 2H), 4.52 – 4.17 
(m, 3H), 4.03 – 3.56 (m, 2H), 3.27 – 3.08 (m, 1H), 1.47 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
173.1, 169.6, 169.4, 164.8, 164.6, 154.9, 134.3, 132.5, 130.7, 128.5, 128.4, 119.7, 95.7 (d, J = 
204.8 Hz), 81.5, 67.2, 47.6 (dd, JC-F = 137.5, 24.1 Hz), 47.3, 46.4, 42.8, 28.3; IR (Neat Film, 
NaCl) 2978, 2926, 1694, 1450, 1414, 1393, 1367, 1329, 1246, 1152, 1042, 999, 979, 926, 857, 
766, 724, 694, 672, 648 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C21H29FN3O6 [M+NH4]+: 
438.2035, found 438.2040. 
 
6-allyl 1-(tert-butyl) 6-fluoro-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1,6-dicarboxylate 
(3h) 
To a 20 mL vial containing allyl ester 2c (320 mg, 0.740 mmol, 1.0 equiv) and NaH (60% 
dispersion in mineral oil, 32.5 mg, 0.814 mmol, 1.1 equiv) was added THF (7.4 mL, 0.1 M) at 23 
°C. After stirring for 30 min, Selectfluor™ (315 mg, 0.889 mmol, 1.2 equiv) was added in a 
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single portion, and the reaction mixture was warmed to 50 °C and stirred for 5 h. The crude 
reaction mixture was then concentrated under reduced pressure and purified by silica gel flash 
chromatography (30% acetone/hexanes) to provide the title compound (290 mg, 0.644 mmol, 
87% yield);	 1H NMR (400 MHz, CDCl3) δ 7.66 – 7.58 (m, 2H), 6.90 – 6.82 (m, 2H), 5.91 (ddt, J 
= 16.3, 10.9, 5.7 Hz, 1H), 5.43 – 5.21 (m, 2H), 4.84 – 4.40 (m, 3H), 4.40 – 4.16 (m, 2H), 4.00 – 
3.86 (m, 1H), 3.82 (s, 3H), 3.77 – 3.56 (m, 1H), 3.22 – 3.09 (m, 1H), 1.47 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 172.6, 169.6 (dd, JC-F = 48.2, 25.4 Hz), 164.9 (d, JC-F = 25.8 Hz), 163.4, 
155.0, 131.3, 130.8, 126.1, 119.8, 113.9, 95.7 (dd, JC-F = 205.6, 14.6 Hz), 81.5, 67.3, 55.5, 47.5 
(dd, JC-F = 109.0, 23.7 Hz), 47.2 (d, JC-F = 92.2 Hz), 43.4, 28.3; IR (Neat Film, NaCl) 2976, 
2936, 2844, 1759, 1698, 1603, 1578, 1512, 1449, 1414, 1367, 1327, 1258, 1168, 1151, 1076, 
1030, 997, 977, 942, 929, 841, 817, 770, 760, 730, 698 cm–1; HRMS (MM: ESI-APCI): m/z 
calc’d for C22H28FN2O7 [M+H]+: 451.1875, found 451.1877. 
 
6-allyl 1-(tert-butyl) 4-(4-methoxybenzoyl)-5-oxo-6-(prop-2-yn-1-yl)-1,4-diazepane-1,6-
dicarboxylate (3i) 
To a solution of allyl ester 2c (250 mg, 0.578 mmol, 1.0 equiv) in THF (5.8 mL, 0.1 M) was 
added NaH (60% dispersion in mineral oil, 25 mg, 0.636 mmol, 1.1 equiv) at 0 °C. After stirring 
for 30 min at 0 °C, propargyl bromide (80% wt/wt in toluene, 125 µL, 1.16 mmol, 2.0 equiv) was 
added at 0 °C. The reaction mixture was heated to 50 °C and stirred for 16 h. The mixture was 
allowed to cool to 23 °C, quenched with aqueous NaHCO3 (10 mL) and extracted with EtOAc (3 
x 5 mL). The combined organic extracts were dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The crude product was purified by automated silica gel 
flash chromatography (Teledyne ISCO, 0→50% acetone/hexanes) to provide propargyl allyl 
ester 3i as a colorless oil (220 mg, 0.468 mmol, 81% yield). 1H NMR (500 MHz, CDCl3) δ 7.73 
– 7.59 (m, 2H), 6.84 (d, J = 8.6 Hz, 2H), 5.99 (ddt, J = 17.3, 10.4, 6.0 Hz, 1H), 5.54 – 5.27 (m, 
2H), 4.85 – 4.69 (m, 2H), 4.33 – 3.85 (m, 4H), 3.82 (s, 3H), 3.76 – 3.56 (m, 1H), 3.56 – 3.39 (m, 
1H), 3.14 – 2.90 (m, 2H), 2.08 (s, 1H), 1.42 (d, J = 14.3 Hz, 9H); 13C NMR (125 MHz, CDCl3) δ 
173.7, 173.2, 170.5, 170.3, 169.7, 169.3, 163.0, 155.6, 154.9, 131.2, 131.0, 127.1, 120.3, 120.0, 
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113.6, 81.1, 81.0, 78.9, 78.6, 72.3, 67.3, 60.7, 60.4, 55.5, 47.1, 46.5, 46.2, 46.0, 43.0, 28.3, 27.0, 
26.9; IR (Neat Film, NaCl) 3280, 2975, 2936, 1737, 1694, 1604, 1579, 1547, 1512, 1454, 1416, 
1393, 1366, 1326, 1280, 1258, 1156, 1134, 1030, 994, 980, 841, 778, 770, 737, 706, 677, 634, 
622 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C25H31N2O7 [M+H]
+: 471. 2126, found 
471.2130. 
 
6-allyl 1-(tert-butyl) 6-(3-methoxy-3-oxopropyl)-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-
1,6-dicarboxylate (3j) 
To a 20 mL vial containing allyl ester 2c (300 mg, 0.694 mmol, 1.0 equiv) and K2CO3 (480 mg, 
3.47 mmol, 5.0 equiv) was added acetone (2.8 mL, 0.25 M) and methyl acrylate (126 µL, 1.39 
mmol, 2.0 equiv) at 23 °C. The vessel was sealed and heated to 50 °C. After stirring for 5 h, 
additional methyl acrylate (126 µL, 1.39 mmol, 2.0 equiv) was added and the reaction was 
stirred for an additional 14 h. The reaction mixture was then filtered through a plug of cotton, 
concentrated under reduced pressure, and purified by silica gel flash chromatography (33% 
EtOAc/petroleum ether) to provide diester 3j as a colorless, waxy solid (185 mg, 0.357 mmol, 
51% yield); 1H NMR (500 MHz, CDCl3) δ 7.77 – 7.65 (m, 2H), 6.92 – 6.79 (m, 2H), 5.96 (ddt, J 
= 17.2, 10.3, 6.1 Hz, 1H), 5.48 – 5.27 (m, 2H), 4.82 – 4.63 (m, 2H), 4.32 – 3.84 (m, 3H), 3.83 (s, 
3H), 3.81 – 3.66 (m, 1H), 3.62 (s, 3H), 3.58 – 3.40 (m, 2H), 2.56 – 2.13 (m, 4H), 1.44 (s, 9H); 
13C NMR (125 MHz, CDCl3) δ 173.8, 173.5, 173.0, 171.9, 170.9, 170.6, 163.0, 155.1, 154.8, 
131.1, 131.0, 127.5, 120.6, 113.6, 81.2, 67.0, 60.4, 55.5, 51.7, 48.7, 47.8, 47.0, 46.0, 43.4, 31.4, 
29.8, 28.3; IR (Neat Film, NaCl) 3354, 2976, 2843, 2568, 2255, 2044, 1694, 1605, 1579, 1556, 
1513, 1416, 1393, 1367, 1260, 1168, 1030, 982, 916, 843, 811, 782, 766, 732, 648, 634 cm–1; 
HRMS (MM: ESI-APCI): m/z calc’d for C26H38N3O9 [M+NH4]+: 536.2603, found 536.2603. 
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6-allyl 1-(tert-butyl) 6-(2-cyanoethyl)-4-(4-methoxybenzoyl)-5-oxo-1,4-diazepane-1,6-
dicarboxylate (3k) 
To a 20 mL vial containing allyl ester 2c (300 mg, 0.694 mmol, 1.0 equiv) and K2CO3 (480 mg, 
3.47 mmol, 5.0 equiv) was added acetone (2.8 mL, 0.25 M) and acrylonitrile (182 µL, 2.78 
mmol, 4.0 equiv) at 23 °C. The vessel was sealed and heated to 50 °C. After 17 h of stirring, the 
reaction mixture was filtered through a plug of cotton, concentrated under reduced pressure, and 
purified by silica gel flash chromatography (33% EtOAc/petroleum ether) to provide 3k as a 
colorless foam (176 mg, 0.362 mmol, 52% yield); 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.8 
Hz, 2H), 6.89 (d, J = 8.9 Hz, 2H), 6.01 (ddt, J = 16.7, 10.3, 6.3 Hz, 1H), 5.51 – 5.36 (m, 2H), 
4.89 – 4.75 (m, 2H), 4.32 – 3.88 (m, 3H), 3.86 (s, 3H), 3.84 – 3.34 (m, 3H), 2.71 – 2.09 (m, 4H), 
1.53 – 1.34 (m, 9H); 13C NMR (100 MHz, CDCl3) δ 170.8, 170.3, 163.2, 155.3, 131.0, 130.6, 
127.1, 121.4, 121.1, 119.1, 113.7, 81.4, 67.5, 60.2, 55.5, 47.5, 46.8, 43.6, 32.9, 28.3, 13.6; IR 
(Neat Film, NaCl) 2975, 2934, 2250, 1694, 1605, 1579, 1512, 1455, 1419, 1393, 1367, 1326, 
1255, 1164, 1031, 1000, 979, 941, 916, 842, 813, 781, 762, 733, 648, 634 cm–1; HRMS (MM: 
ESI-APCI): m/z calc’d for C25H35N4O7 [M+NH4]+: 503.2500, found 503.2505. 
 
6-allyl 1-(tert-butyl) 4-benzoyl-6-(((tert-butoxycarbonyl)amino)methyl)-5-oxo-1,4- 
diazepane-1,6-dicarboxylate (3l) 
A solution of allyl ester 2a (200 mg, 0.497 mmol, 1.0 equiv) and tert-butyl 
((phenylsulfonyl)methyl)carbamate5,6 (162 mg, 0.597 mmol, 1.2 equiv) in CH2Cl2 (2.5 mL, 0.2 
M) at 23 °C was stirred for 5 min, after which time Cs2CO3 (405 mg, 1.24 mmol, 2.5 equiv) was 
added at the same temperature. After an additional 30 min of stirring, saturated aqueous NH4Cl 
(1 mL) was added and the biphasic mixture was vigorously stirred for 20 min. The layers were 
separated and the aqueous phase was extracted with CH2Cl2 (3 x 3 mL). The combined organic 
extracts were dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure 
onto silica gel (2 g). The silica-adsorbed crude reaction mixture was purified by automated silica 
gel flash chromatography (Teledyne ISCO, 10→40% acetone/hexanes) to provide carbamate 3l 
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as a white foam (200 mg, 0.376 mmol, 76% yield): 1H NMR (400 MHz, CDCl3) δ 7.83 – 7.71 
(m, 2H), 7.59 – 7.46 (m, 1H), 7.46 – 7.36 (m, 2H), 6.00 (ddt, J = 16.6, 10.3, 6.1 Hz, 1H), 5.51 – 
5.25 (m, 2H), 5.17 (br s, 1H), 4.79 – 4.64 (m, 2H), 4.48 – 4.23 (m, 1H), 4.14 – 3.20 (m, 7H), 
1.44 (s, 9H), 1.42 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 174.1, 173.8, 172.7, 170.1, 169.6, 
156.0, 155.2, 154.7, 135.5, 132.2, 131.4, 128.5, 128.4, 120.2, 81.4, 79.6, 67.4, 62.7, 47.1, 46.8, 
45.9, 43.2, 28.5, 28.4; IR (Neat Film, NaCl) 3457, 2977, 2934, 2253, 1704, 1600, 1503, 1450, 
1417, 1392, 1367, 1325, 1283, 1248, 1158, 1042, 980, 913,77 860, 767, 729, 693, 663 cm–1; 
HRMS (MM: ESI-APCI): m/z calc’d for C27H38N3O8 [M+H]
+: 532.2653, found 532.2664. 
Derivatization of Allylic Alkylation Products 
 
2-bromo-5-chlorobenzo[d]oxazole (6) 
Prepared according to the literature procedure by Mangion and coworkers7 and used directly in 
the synthesis of 7. 
 
5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid (8) 
Prepared according to the literature procedure by Mangion and coworkers.7 All characterization 
data matched those reported in the literature. 
 
tert-butyl (S)-6-allyl-6-benzyl-5-oxo-1,4-diazepane-1-carboxylate (SI4) 
To a flask containing benzoyl-protected diazepanone 4a (460 mg, 1.03 mmol, 1.0 equiv) was 
added isopropyl alcohol (100 mL, 0.01 M) and water (10 mL), followed by LiOH·H2O (61 mg, 
1.45 mmol, 1.5 equiv) at 23 °C. After stirring for 4 h at 23 °C, the isopropyl alcohol was 
removed under reduced pressure and the resulting aqueous mixture extracted with EtOAc (4 x 50 
N
O
Br
Cl
Me
CO2H
N
N
N
HN
NBoc
Bn
HN
NBoc
O Bn
BzN
NBoc
O Bn LiOH·H2O
i-PrOH/H2O, 23 °C, 5 h
LiAlH4
THF, 0 °C, 4 h
4a 5SI4
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mL). The combined organic extracts were dried with sodium sulfate, filtered, and concentrated 
under reduced pressure to yield a crude oil (400 mg) that was used without further purification. 
tert-butyl (R)-6-allyl-6-benzyl-1,4-diazepane-1-carboxylate (5) 
 Crude lactam SI4 (350 mg [theoretical maximum 310 mg lactam], 0.903 mmol, 1 equiv) 
was dissolved in THF (10.2 mL, 0.1 M) and cooled to 0 °C. LiAlH4 (77 mg, 2.03 mmol, 2.25 
equiv) was then added, and the reaction mixture was stirred at 0 °C for 4 h, over the course of 
which an additional 3.37 equiv (116 mg, 3.05 mmol) of LiAlH4 were added in total (77 mg, 
followed by 39 mg, at equal intervals). The reaction mixture was then diluted with diethyl ether 
(10 mL) and water (300 µL) was added. After gas generation subsided, 15% aqueous NaOH (300 
µL) was added, followed by additional water (900 µL). After stirring at 0 °C for 15 min, 
anhydrous MgSO4 was added, and the mixture was stirred for an additional 10 min, whereafter it 
was filtered through celite and concentrated under reduced pressure. Purification by automated 
silica gel flash chromatography (Teledyne ISCO, 0→20% MeOH/CH2Cl2) provided the product 
as a light yellow oil (130 mg, 0.393 mmol, 44% yield); 1H NMR (400 MHz, CDCl3) δ 7.40 – 
7.14 (m, 5H), 6.01 (dq, J = 17.1, 7.8 Hz, 1H), 5.18 (d, J = 15.9 Hz, 2H), 3.67 – 3.30 (m, 4H), 
2.97 (m, 2H), 2.88 – 2.48 (m, 4H), 2.30 – 2.06 (m, 3H), 1.50 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 155.8, 138.1, 134.6, 130.7, 128.0, 126.2, 118.2, 79.8, 79.5, 57.9, 57.2, 55.3, 54.2, 50.9, 
49.8, 49.3, 43.5, 41.3, 39.8, 39.4, 28.5; IR (Neat Film, NaCl) 3357, 3066, 3028, 2976, 2928, 
1694, 1602, 1464, 1455, 1416, 1391, 1365, 1334, 1302, 1248, 1166, 1031, 996, 952, 912, 866, 
771, 733, 703, 685, 672, 659, 644, 612 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for 
C20H31N2O2 [M+H]+: 331.2380, found 331.2399; [α]D22.24 –6.496 (c 2.0, CHCl3). 
 
tert-butyl (R)-6-allyl-6-benzyl-4-(5-chlorobenzo[d]oxazol-2-yl)-1,4-diazepane-1-carboxylate 
(SI5) 
To a 1 dram vial containing diazepane 5 (9.5 mg, 0.0287 mmol, 1.0 equiv), aryl bromide 
6 (10.0 mg, 0.0431 mmol, 1.5 equiv), and K2CO3 (7.9 mg, 0.0574 mmol, 2 equiv) was added 
HN
NBoc
Bn N
NBocBn
N
O
Cl
N
NHBn
N
O
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AcCl, MeOH
23 °C, 5 h
6, K2CO3
MeCN, 23 °C, 24 h
5
7
SI5
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MeCN (0.3 mL, 0.1 M) at 23 °C. After stirring for 24 h at 23 °C, saturated aqueous NH4Cl (1 
mL) was added, and the mixture was extracted with EtOAc (3 x 1 mL). The combined organic 
extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude 
material (15.4 mg) thus obtained was carried forward without further purification. 
(S)-2-(6-allyl-6-benzyl-1,4-diazepan-1-yl)-5-chlorobenzo[d]oxazole (7) 
Crude carbamate SI5 was dissolved in MeOH (0.3 mL, 0.1 M) and AcCl (20.5 µL, 0.288 
mmol, 10 equiv) was added at 23 °C. After stirring for 5 h at 23 °C, the reaction mixture was 
concentrated under reduced pressure and purified by silica gel flash chromatography (66% 
EtOAc/benzene + 1% Et3N) to provide 7 as a beige, amorphous solid (4.3 mg, 0.0113 mmol, 
39% yield from 5) of sufficient purity for use in the next reaction, however, further purification 
was possible by silica gel flash chromatography with 2% Et3N in Et2O; 1H NMR (400 MHz, 
CDCl3) δ 7.34 – 7.27 (m, 3H), 7.25 – 7.17 (m, 3H), 7.12 (d, J = 8.4 Hz, 1H), 6.94 (dd, J = 8.4, 
2.3 Hz, 1H), 5.99 (ddt, J = 14.5, 10.4, 7.2 Hz, 1H), 5.30 (d, J = 3.1 Hz, 1H), 5.20 – 5.10 (m, 1H), 
3.87 – 3.61 (m, 3H), 3.15 – 3.00 (m, 2H), 2.90 – 2.66 (m, 3H), 2.57 (d, J = 13.9 Hz, 1H), 2.22 – 
2.10 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 147.5, 137.8, 134.1, 130.8, 129.4, 128.2, 126.4, 
120.1, 118.8, 116.2, 109.2, 57.8, 56.5, 53.3, 49.2, 43.8, 41.3, 39.8; IR (Neat Film, NaCl) 2922, 
1638, 1570, 1458, 1249, 1167, 921, 792, 710 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for 
C22H25ClN3O [M+H]+: 382.1681, found 382.1695; [α]D21.89 +7.524 (c 0.07, CHCl3). 
 
(R)-(6-allyl-6-benzyl-4-(5-chlorobenzo[d]oxazol-2-yl)-1,4-diazepan-1-yl)(5-methyl-2-(2H-
1,2,3-triazol-2-yl)phenyl)methanone (9) 
To a vial containing carboxylic acid 8 (35 mg, 0.172 mmol, 1.0 equiv) in CH2Cl2 (1.8 mL) at 23 
°C was added DMF (4 µL, 0.0517 mmol, 0.3 equiv) and oxalyl chloride (18 µL, 0.207 mmol, 1.2 
equiv). After stirring for 1 h, Et3N (48 µL, 0.344 mmol, 2.0 equiv) was added, followed by 
amine 7 (60 mg, 0.155 mmol, 0.9 equiv) in CH2Cl2 (1.8 mL, 0.05 M total concentration). After 
stirring for an additional 1 h at 23 °C, the reaction mixture was quenched with saturated aqueous 
NaHCO3 (3 mL), the layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 
N N
Bn
N
O
Cl
Me
N N
NO
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 	
 
S34 
x 2 mL). The combined organic extracts were dried over anhydrous Na2SO4, concentrated under 
reduced pressure, and purified by automated silica gel flash chromatography (Teledyne ISCO, 
0→40% Et2O/hexanes) to provide amide 9 as a beige oil (29.6 mg, 0.0522 mmol, 34% yield); 1H 
NMR (400 MHz, CDCl3) δ 7.73 (s, 1H), 7.55 (s, 1H), 7.34 – 7.27 (m, 6H), 7.20 – 7.09 (m, 3H), 
7.04 – 6.92 (m, 2H), 6.11 (ddt, J = 17.6, 10.4, 7.3 Hz, 1H), 5.26 – 5.12 (m, 2H), 4.24 – 4.07 (m, 
1H), 3.96 (dd, J = 17.1, 14.4 Hz, 1H), 3.90 – 3.75 (m, 1H), 3.70 – 3.40 (m, 4H), 3.38 – 3.12 (m, 
2H), 2.99 – 2.80 (m, 2H), 2.43 – 2.38 (m, 2H), 2.38 – 2.33 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 170.7, 170.5, 170.0, 163.0, 147.2, 144.4, 138.7, 138.6, 138.5, 136.9, 135.9, 135.8, 
135.8, 135.7, 135.7, 135.6, 135.6, 134.2, 133.9, 133.8, 133.6, 133.5, 133.2, 132.9, 130.9, 130.8, 
130.6, 130.6, 130.4, 130.4, 129.9, 129.5, 129.5, 129.0, 129.0, 128.3, 128.3, 128.2, 128.2, 128.2, 
128.1, 128.1, 126.6, 126.6, 122.2, 122.0, 121.9, 120.5, 120.5, 119.2, 119.1, 119.0, 116.3, 116.3, 
109.3, 109.2, 56.2, 56.1, 55.5, 54.3, 52.9, 52.2, 49.5, 49.3, 49.2, 48.9, 47.6, 45.0, 43.5, 43.1, 42.4, 
42.2, 42.0, 41.8, 39.5, 39.5, 37.6, 21.0, 21.0, 20.9; IR (Neat Film, NaCl) 3431, 2923, 2854, 2356, 
1644, 1634, 1574, 1568, 1538, 1505, 1462, 1454, 1428, 1372, 1308, 1251, 1216, 1172, 1054, 
952, 921, 852, 822, 794, 737, 704 cm–1; HRMS (MM: ESI-APCI): m/z calc’d for C32H32ClN6O2 
[M+H]+: 567.2270, found 567.2294; [α]D22.24 +41.90 (c 1.0, CHCl3). 
 																																																								
References 
1) Pangborn, A. M.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Safe and 
Convenient Procedure for Solvent Purification. Organometallics 1996, 15, 1518–1520. 
2) a) Behenna, D. C; Stoltz, B. M. The Enantioselective Tsuji Allylation. J. Am. Chem. Soc. 
2004, 126, 15044–15045. b) Mohr, J. T.; Behenna, D. C.; Harned, A. M.; Stoltz, B. M. 
Deracemization of Quaternary Stereocenters by Pd-Catalyzed Enantioconvergent 
Decarboxylative Allylation of Racemic β-Ketoesters. Angew. Chem. Int. Ed. 2005, 44, 
6924–6927. c) Seto, M.; Roizen, J. L.; Stoltz, B. M. Catalytic Enantioselective Alkylation 
of Substituted Dioxanone Enol Ethers: Ready Access to C(α)-Tetrasubstituted 
Hydroxyketones, Acids, and Esters. Angew. Chem. Int. Ed. 2008, 47, 6873–6876. d) 
Streuff, J.; White, D. E.; Virgil, S. C.; Stoltz, B. M. A palladium-catalysed enolate 
alkylation cascade for the formation of adjacent quaternary and tertiary stereocentres. 
Nat. Chem. 2010, 2, 192–196. e) Behenna, D. C.; Liu, Y.; Yurino, T.; Kim, J.; White, D. 
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 	
 
S35 
																																																																																																																																																																																		
E.; Virgil, S. C.; Stoltz, B. M. Enantioselective construction of quaternary N-heterocycles 
by palladium-catalysed decarboxylative allylic alkylation of lactams. Nat. Chem. 2012, 4, 
130–133. f) Reeves, C. M.; Eidamshaus, C.; Kim, J.; Stoltz, B. M. Enantioselective 
Construction of α-Quaternary Cyclobutanones by Catalytic Asymmetric Allylic 
Alkylation. Angew. Chem. Int. Ed. 2013, 52, 6718–6721. 
3) McDougal, N. T.; Streuff, J.; Mukherjee, H.; Virgil, S. C.; Stoltz, B. M. Rapid synthesis 
of an electron-deficient t-BuPHOX ligand: cross-coupling of aryl bromides with 
secondary phosphine oxides. Tetrahedron Lett. 2010, 51, 5550–5554. 
4)  Alexy, E. J.; Fulton, T. J.; Zhang, H.; Stoltz, B. M. Palladium-catalyzed enantioselective 
decarboxylative allylic alkylation of fully substituted N-acyl indole-derived enol 
carbonates. Chem. Sci. 2019, 10, 5996–6000. 
5)  Klepacz, A.; Zwierzak, A. An expeditious one-pot synthesis of diethyl N-Boc-1-
aminoalkylphosphonates. Tetrahedron Lett. 2002, 43, 1079–1080. 
6)  Sikriwal, D.; Kant, R.; Maulik, P. R.; Dikshit, D. K. A short formal synthesis of three 
epimers of penmacric acid. Tetrahedron 2010, 66, 6167–6173. 
7)  Mangion, I. K.; Sherry, B. D.; Yin, J.; Fleitz, F. J. Enantioselective Synthesis of a Dual 
Orexin Receptor Antagonist. Org. Lett. 2012, 14, 3458–3461. 
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 
 
S36 
NMR and IR Spectra of New Compounds  
Bz
N
NB
oc
O
Bn 4a
 1 H
 N
M
R
 (4
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
4a
. 
 
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 
 
S37 
 
  
Infrared spectrum (Thin Film, NaCl) of compound 4a. 
 
 13C NMR (100 MHz, CDCl3) of compound 4a. 
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Infrared spectrum (Thin Film, NaCl) of compound 4b. 
 
 13C NMR (100 MHz, CDCl3) of compound 4b. 
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Infrared spectrum (Thin Film, NaCl) of compound 4c. 
 
 13C NMR (100 MHz, CDCl3) of compound 4c. 
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Infrared spectrum (Thin Film, NaCl) of compound 4d. 
 
 13C NMR (100 MHz, CDCl3) of compound 4d. 
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Infrared spectrum (Thin Film, NaCl) of compound 4e. 
 
 13C NMR (100 MHz, CDCl3) of compound 4e. 
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Infrared spectrum (Thin Film, NaCl) of compound 4f. 
 
 13C NMR (100 MHz, CDCl3) of compound 4f. 
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Infrared spectrum (Thin Film, NaCl) of compound 4g. 
 
 13C NMR (100 MHz, CDCl3) of compound 4g. 
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Infrared spectrum (Thin Film, NaCl) of compound 4h. 
 
 13C NMR (100 MHz, CDCl3) of compound 4h. 
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Infrared spectrum (Thin Film, NaCl) of compound 4i. 
 
 13C NMR (100 MHz, CDCl3) of compound 4i. 
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Infrared spectrum (Thin Film, NaCl) of compound 4j. 
 
 13C NMR (100 MHz, CDCl3) of compound 4j. 
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Infrared spectrum (Thin Film, NaCl) of compound 4k. 
 
 13C NMR (100 MHz, CDCl3) of compound 4k. 
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Infrared spectrum (Thin Film, NaCl) of compound 4l. 
 
 13C NMR (100 MHz, CDCl3) of compound 4l. 
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Infrared spectrum (Thin Film, NaCl) of compound SI1. 
 
 13C NMR (100 MHz, CDCl3) of compound SI1. 
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Infrared spectrum (Thin Film, NaCl) of compound SI2. 
 
 13C NMR (100 MHz, CDCl3) of compound SI2. 
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Infrared spectrum (Thin Film, NaCl) of compound SI3. 
 
 13C NMR (100 MHz, CDCl3) of compound SI3. 
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Infrared spectrum (Thin Film, NaCl) of compound 2a. 
 
 13C NMR (125 MHz, CDCl3) of compound 2a. 
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Infrared spectrum (Thin Film, NaCl) of compound 2b. 
 
 13C NMR (100 MHz, CDCl3) of compound 2b. 
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Infrared spectrum (Thin Film, NaCl) of compound 2c. 
 
 13C NMR (100 MHz, CDCl3) of compound 2c. 
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Infrared spectrum (Thin Film, NaCl) of compound 3a. 
 
 13C NMR (100 MHz, CDCl3) of compound 3a. 
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Infrared spectrum (Thin Film, NaCl) of compound 3b. 
 
 13C NMR (100 MHz, CDCl3) of compound 3b. 
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Infrared spectrum (Thin Film, NaCl) of compound 3c. 
 
 13C NMR (100 MHz, CDCl3) of compound 3c. 
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Infrared spectrum (Thin Film, NaCl) of compound 3d. 
 
 13C NMR (100 MHz, CDCl3) of compound 3d. 
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Infrared spectrum (Thin Film, NaCl) of compound 3e. 
 
 13C NMR (125 MHz, CDCl3) of compound 3e. 
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Infrared spectrum (Thin Film, NaCl) of compound 3f. 
 
 13C NMR (100 MHz, CDCl3) of compound 3f. 
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Infrared spectrum (Thin Film, NaCl) of compound 3g. 
 
 13C NMR (125 MHz, CDCl3) of compound 3g. 
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Infrared spectrum (Thin Film, NaCl) of compound 3h. 
 
 13C NMR (100 MHz, CDCl3) of compound 3h. 
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Infrared spectrum (Thin Film, NaCl) of compound 3i. 
 
 13C NMR (125 MHz, CDCl3) of compound 3i. 
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Infrared spectrum (Thin Film, NaCl) of compound 3j. 
 
 13C NMR (125 MHz, CDCl3) of compound 3j. 
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Infrared spectrum (Thin Film, NaCl) of compound 3k. 
 
 13C NMR (100 MHz, CDCl3) of compound 3k. 
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Infrared spectrum (Thin Film, NaCl) of compound 3l. 
 
 13C NMR (100 MHz, CDCl3) of compound 3l. 
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Infrared spectrum (Thin Film, NaCl) of compound 5. 
 
 13C NMR (100 MHz, CDCl3) of compound 5. 
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Infrared spectrum (Thin Film, NaCl) of compound 7. 
 
 13C NMR (100 MHz, CDCl3) of compound 7. 
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Infrared spectrum (Thin Film, NaCl) of compound 9. 
 
 13C NMR (100 MHz, CDCl3) of compound 9. 
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Variable-Temperature NMR of Diazepanone 4e 
 
  
 1 H
 N
M
R
 (4
00
 M
H
z,
 D
M
SO
-d
6, 
23
.3
 °
C
) o
f c
om
po
un
d 
4e
. 
 
An
N
NB
oc
O
Bn 4e
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 
 
S103 
  
 1 H
 N
M
R
 (4
00
 M
H
z,
 D
M
SO
-d
6, 
80
 °
C
) o
f c
om
po
un
d 
4e
. 
 
An
N
NB
oc
O
Bn 4e
Supporting Information for Sercel,‡ Sun,‡ and Stoltz 
 
S104 
 
 
 
 
 
 
 13C NMR (100 MHz, DMSO-d6, 80 °C) of compound 4e. 
 
